274 related articles for article (PubMed ID: 26337079)
1. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
2. Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.
Heerma van Voss MR; Vesuna F; Trumpi K; Brilliant J; Berlinicke C; de Leng W; Kranenburg O; Offerhaus GJ; Bürger H; van der Wall E; van Diest PJ; Raman V
Oncotarget; 2015 Sep; 6(29):28312-26. PubMed ID: 26311743
[TBL] [Abstract][Full Text] [Related]
3. RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.
Xie M; Vesuna F; Tantravedi S; Bol GM; Heerma van Voss MR; Nugent K; Malek R; Gabrielson K; van Diest PJ; Tran PT; Raman V
Cancer Res; 2016 Nov; 76(21):6340-6350. PubMed ID: 27634756
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer.
Inao T; Harashima N; Monma H; Okano S; Itakura M; Tanaka T; Tajima Y; Harada M
Breast Cancer Res Treat; 2012 Jul; 134(1):89-100. PubMed ID: 22203435
[TBL] [Abstract][Full Text] [Related]
5. In vitro anti-cancer activity of doxorubicin against human RNA helicase, DDX3.
Botlagunta M; Kollapalli B; Kakarla L; Gajarla SP; Gade SP; Dadi CL; Penumadu A; Javeed S
Bioinformation; 2016; 12(7):347-353. PubMed ID: 28246464
[TBL] [Abstract][Full Text] [Related]
6. Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication.
Yedavalli VS; Zhang N; Cai H; Zhang P; Starost MF; Hosmane RS; Jeang KT
J Med Chem; 2008 Aug; 51(16):5043-51. PubMed ID: 18680273
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
8. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
9. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
[TBL] [Abstract][Full Text] [Related]
10. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss MR; Vesuna F; Bol GM; Afzal J; Tantravedi S; Bergman Y; Kammers K; Lehar M; Malek R; Ballew M; Ter Hoeve N; Abou D; Thorek D; Berlinicke C; Yazdankhah M; Sinha D; Le A; Abrahams R; Tran PT; van Diest PJ; Raman V
Oncogene; 2018 Jan; 37(1):63-74. PubMed ID: 28869602
[TBL] [Abstract][Full Text] [Related]
11. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
[TBL] [Abstract][Full Text] [Related]
13. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assembly.
Cui BC; Sikirzhytski V; Aksenova M; Lucius MD; Levon GH; Mack ZT; Pollack C; Odhiambo D; Broude E; Lizarraga SB; Wyatt MD; Shtutman M
Biochem Pharmacol; 2020 Dec; 182():114280. PubMed ID: 33049245
[TBL] [Abstract][Full Text] [Related]
15. Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer.
Samal SK; Routray S; Veeramachaneni GK; Dash R; Botlagunta M
Sci Rep; 2015 Apr; 5():9982. PubMed ID: 25918862
[TBL] [Abstract][Full Text] [Related]
16. A Computational Approach with Biological Evaluation: Combinatorial Treatment of Curcumin and Exemestane Synergistically Regulates DDX3 Expression in Cancer Cell Lines.
Rampogu S; Kim SM; Son M; Baek A; Park C; Lee G; Kim Y; Kim GS; Kim JH; Lee KW
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32512851
[TBL] [Abstract][Full Text] [Related]
17. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
18. DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway.
Chen HH; Yu HI; Cho WC; Tarn WY
Oncogene; 2015 May; 34(21):2790-800. PubMed ID: 25043297
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approach.
Doneti R; Pasha A; Botlagunta M; Heena SK; Mutyala VVVP; Pawar SC
Med Oncol; 2022 Sep; 39(11):179. PubMed ID: 36048256
[TBL] [Abstract][Full Text] [Related]
20. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]